المؤلفون: Massaro F., Pavone V., Stefani P. M., Botto B., Pulsoni A., Patti C., Cantonetti M., Visentin A., Scalzulli P. R., Rossi A., Galimberti S., Cimminiello M., Gini G., Musso M., Sorio M., Arcari A., Zilioli V. R., Luppi M., Mannina D., Fabbri A., Pietrantuono G., Annibali O., Tafuri A., Prete E., Mule A., Barbolini E., Marcheselli L., Luminari S., Merli F.

المساهمون: Massaro, F., Pavone, V., Stefani, P. M., Botto, B., Pulsoni, A., Patti, C., Cantonetti, M., Visentin, A., Scalzulli, P. R., Rossi, A., Galimberti, S., Cimminiello, M., Gini, G., Musso, M., Sorio, M., Arcari, A., Zilioli, V. R., Luppi, M., Mannina, D., Fabbri, A., Pietrantuono, G., Annibali, O., Tafuri, A., Prete, E., Mule, A., Barbolini, E., Marcheselli, L., Luminari, S., Merli, F.

مصطلحات موضوعية: AETHERA trial, autologous stem cell transplantation, brentuximab vedotin, hodgkin lymphoma, Adolescent, Adult, Aged, Antineoplastic Agents, Immunological, Combined Modality Therapy, Female, Follow-Up Studie, Hematopoietic Stem Cell Transplantation, Hodgkin Disease, Human, Male, Middle Aged, Prognosi, Retrospective Studie, Survival Rate, Young Adult

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34694649; info:eu-repo/semantics/altIdentifier/wos/WOS:000713467600001; volume:40; issue:1; firstpage:31; lastpage:39; numberofpages:9; journal:HEMATOLOGICAL ONCOLOGY; http://hdl.handle.net/11380/1269519Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85118336432

الإتاحة: https://doi.org/10.1002/hon.2939Test
http://hdl.handle.net/11380/1269519Test

المؤلفون: Ricardi U., Levis M., Evangelista A., Gioia D. M., Sacchetti G. M., Gotti M., Re A., Buglione M., Pavone V., Nardella A., Nassi L., Zanni M., Franzone P., Frezza G. P., Pulsoni A., Grapulin L., Santoro A., Rigacci L., Simontacchi G., Tani M., Zaja F., Abruzzese E., Botto B., Zilioli V. R., Rota-Scalabrini D., Freilone R., Ciccone G., Filippi A. R., Zinzani P. L.

المساهمون: Ricardi, U., Levis, M., Evangelista, A., Gioia, D. M., Sacchetti, G. M., Gotti, M., Re, A., Buglione, M., Pavone, V., Nardella, A., Nassi, L., Zanni, M., Franzone, P., Frezza, G. P., Pulsoni, A., Grapulin, L., Santoro, A., Rigacci, L., Simontacchi, G., Tani, M., Zaja, F., Abruzzese, E., Botto, B., Zilioli, V. R., Rota-Scalabrini, D., Freilone, R., Ciccone, G., Filippi, A. R., Zinzani, P. L.

مصطلحات موضوعية: Antineoplastic Combined Chemotherapy Protocol, Bleomycin, Dacarbazine, Doxorubicin, Human, Neoplasm Staging, Vinblastine, Hodgkin Disease

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34597375; info:eu-repo/semantics/altIdentifier/wos/WOS:000718993700021; volume:5; issue:21; firstpage:4504; lastpage:4514; numberofpages:11; journal:BLOOD ADVANCES; http://hdl.handle.net/11368/3005933Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85118828593; https://ashpublications.org/bloodadvances/article/5/21/4504/477135/Role-of-radiotherapy-to-bulky-sites-of-advancedTest; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579271Test/

الإتاحة: https://doi.org/10.1182/bloodadvances.2021005150Test
http://hdl.handle.net/11368/3005933Test
https://ashpublications.org/bloodadvances/article/5/21/4504/477135/Role-of-radiotherapy-to-bulky-sites-of-advancedTest
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579271Test/

المؤلفون: Mondello P., Musolino C., Dogliotti I., Bohn J. -P., Cavallo F., Ferrero S., Botto B., Cerchione C., Nappi D., De Lorenzo S., Martinelli G., Wolf D., Schmitt C., Loseto G., Cuzzocrea S., Willenbacher W., Mian M., Straus D. J.

المساهمون: Mondello P., Musolino C., Dogliotti I., Bohn J.-P., Cavallo F., Ferrero S., Botto B., Cerchione C., Nappi D., De Lorenzo S., Martinelli G., Wolf D., Schmitt C., Loseto G., Cuzzocrea S., Willenbacher W., Mian M., Straus D.J.

مصطلحات موضوعية: Adult, Aged, Antineoplastic Combined Chemotherapy Protocol, Austria, Bleomycin, Cyclophosphamide, Dacarbazine, Disease-Free Survival, Doxorubicin, Etoposide, Female, Follow-Up Studie, Human, Italy, Male, Middle Aged, Neoplasm Staging, Prednisone, Procarbazine, Survival Rate, Vinblastine, Vincristine, Hodgkin Disease

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32419224; info:eu-repo/semantics/altIdentifier/wos/WOS:000544095300001; volume:95; issue:9; firstpage:1030; lastpage:1037; numberofpages:8; journal:AMERICAN JOURNAL OF HEMATOLOGY; http://hdl.handle.net/2318/1790895Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85087183944

الإتاحة: https://doi.org/10.1002/ajh.25871Test
http://hdl.handle.net/2318/1790895Test

المؤلفون: Bari A., Marcheselli R., Sacchi S., Re A., Pagani C., Tucci A., Botto B., Vitolo U., Molinari A. L., Puccini B., Pulsoni A., Santoro A., Tani M., Nassi L., Meli E., Pavone V., Bonfichi M., Evangelista A., Gioia D., Levis A., Zinzani P.

المساهمون: Bari, A., Marcheselli, R., Sacchi, S., Re, A., Pagani, C., Tucci, A., Botto, B., Vitolo, U., Molinari, A. L., Puccini, B., Pulsoni, A., Santoro, A., Tani, M., Nassi, L., Meli, E., Pavone, V., Bonfichi, M., Evangelista, A., Gioia, D., Levis, A., Zinzani, P.

مصطلحات موضوعية: Absolute monocyte count, Hodgkin lymphoma, International Prognostic Score, Neutrophil lymphocyte ratio, PET, Adult, Antineoplastic Combined Chemotherapy Protocol, Autograft, Bleomycin, Dacarbazine, Disease-Free Survival, Doxorubicin, Female, Human, Male, Middle Aged, Neoplasm Staging, Positron-Emission Tomography, Survival Rate, Vinblastine, Hodgkin Disease, Stem Cell Transplantation

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31872362; info:eu-repo/semantics/altIdentifier/wos/WOS:000504172600002; volume:99; issue:2; firstpage:277; lastpage:282; journal:ANNALS OF HEMATOLOGY; http://hdl.handle.net/11380/1203344Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85077165510

الإتاحة: https://doi.org/10.1007/s00277-019-03893-7Test
http://hdl.handle.net/11380/1203344Test

المؤلفون: Broccoli A., Argnani L., Botto B., Corradini P., Pinto A., Re A., Vitolo U., Fanti S., Stefoni V., Zinzani P. L.

المساهمون: A. Broccoli, L. Argnani, B. Botto, P. Corradini, A. Pinto, A. Re, U. Vitolo, S. Fanti, V. Stefoni, P.L. Zinzani

مصطلحات موضوعية: Adult, Aged, Antineoplastic Combined Chemotherapy Protocol, Bendamustine Hydrochloride, Brentuximab Vedotin, Combined Modality Therapy, Female, Hodgkin Disease, Human, Magnetic Resonance Imaging, Male, Middle Aged, Neoplasm Grading, Salvage Therapy, Tomography, X-Ray Computed, Treatment Outcome, Young Adult, Settore MED/15 - Malattie del Sangue

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31827067; info:eu-repo/semantics/altIdentifier/wos/WOS:000502874400001; volume:9; issue:12; firstpage:1; lastpage:8; numberofpages:8; journal:BLOOD CANCER JOURNAL; http://hdl.handle.net/2434/737071Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85076499232

الإتاحة: https://doi.org/10.1038/s41408-019-0265-xTest
http://hdl.handle.net/2434/737071Test

المؤلفون: Aglietta, M, Montemurro, F, Fagioli, F, Volta, C, Botto, B, Cantonetti, M, Racanelli, V, Teofili, L, Amadori, S, Castoldi, GL, Dammacco, F, Levis, A, Ferrara, R

المساهمون: Aglietta, M, Montemurro, F, Fagioli, F, Volta, C, Botto, B, Cantonetti, M, Racanelli, V, Teofili, L, Ferrara, R, Amadori, S, Castoldi, GL, Dammacco, F, Levis, A

مصطلحات موضوعية: Hodgkin disease, hybrid mechlorethamine, vincristine, procarbazine, and prednisone, doxorubicin, bleomycin, vinblastine, and dacarbazine, granulocyte-macrophage-colony stimulating factor, myeloprotection

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000084793600028; volume:88; issue:2; firstpage:454; lastpage:460; numberofpages:7; journal:CANCER; http://hdl.handle.net/2318/1844103Test

الإتاحة: https://doi.org/10.1002Test/(SICI)1097-0142(20000115)88:2<454::AID-CNCR28>3.0.CO;2-Q
http://hdl.handle.net/2318/1844103Test

المؤلفون: Aglietta, M. ai, Montemurro, F. a, Fagioli, F. b, Volta, C. c, Botto, B. d, Racanelli, V. f, Teofili, L. g, Ferrara, R. h, Castoldi, G. L. b, Dammacco, F. f, Levis, A. d., CANTONETTI, MARIA, AMADORI, SERGIO

المساهمون: Aglietta, Ma, Montemurro, Fa, Fagioli, Fb, Volta, Cc, Botto, Bd, Cantonetti, M, Racanelli, Vf, Teofili, Lg, Ferrara, Rh, Amadori, S, Castoldi, Glb, Dammacco, Ff, Levis, Ad

مصطلحات موضوعية: Granulocyte- macrophage-colony stimulating factor, Hodgkin disease, Hybrid mechlorethamine, Myeloprotection, Vincristine, procarbazine, and prednisone, doxorubicin, bleomycin, vinblastine, and dacarbazine, Settore MED/15 - MALATTIE DEL SANGUE, Settore MED/06 - ONCOLOGIA MEDICA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/10640980; info:eu-repo/semantics/altIdentifier/wos/WOS:000084793600028; volume:88; issue:2; firstpage:454; lastpage:460; journal:CANCER; http://hdl.handle.net/2108/69289Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-0034650462

الإتاحة: http://hdl.handle.net/2108/69289Test

المؤلفون: Aglietta, M., Montemurro, F., Fagioli, F., Volta, C., Botto, B., Cantonetti, M., Racanelli, V., Teofili, L., Amadori, S., Castoldi, G. L., Dammacco, F., Levis, A., Ferrara, R.

مصطلحات موضوعية: procarbazine, Hodgkin disease, bleomycin, Settore MED/06 - Oncologia Medica, Granulocyte- macrophage-colony stimulating factor, Hybrid mechlorethamine, doxorubicin, and dacarbazine, Myeloprotection, Vincristine, vinblastine, and prednisone, Vincristine, procarbazine, and prednisone, doxorubicin, bleomycin, vinblastine, and dacarbazine, Settore MED/15 - Malattie del Sangue

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::00d7d4a424b3373334a06b2ba6fad818Test
http://hdl.handle.net/2108/69289Test

المؤلفون: Levis A, Depaoli L, Bertini M, Botto B, Ciravegna G, ROBERTO FREILONE, Gallamini A, Gavarotti P, Ricardi U, Rota Scalabrini D, Salomone A, Salvi F, Vitolo U, Pileri A, Gl, Sannazzari, Resegotti L

المصدر: Scopus-Elsevier
Europe PubMed Central

مصطلحات موضوعية: Aged, 80 and over, Bleomycin, Treatment Outcome, Vincristine, Antineoplastic Combined Chemotherapy Protocols, Humans, Prednisone, Cyclophosphamide, Hodgkin Disease, Aged, Carboplatin, Etoposide

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::10ddb02bc3a135a3d5783ed6bdf7233fTest
http://www.scopus.com/inward/record.url?eid=2-s2.0-0030324493&partnerID=MN8TOARSTest

المؤلفون: Alessandro Re, Luca Nassi, Armando Santoro, Daniela Gioia, Vittorio Ruggero Zilioli, Paola Franzone, Alessandro Pulsoni, Pier Luigi Zinzani, Luigi Rigacci, Monica Tani, Francesco Zaja, Mario Levis, Gabriele Simontacchi, Umberto Ricardi, Manuela Zanni, Antonio Nardella, Vincenzo Pavone, Michela Buglione, Andrea Riccardo Filippi, Delia Rota-Scalabrini, Manuel Gotti, Barbara Botto, Giovanni Frezza, Elisabetta Abruzzese, Gian Mauro Sacchetti, Lavinia Grapulin, Roberto Freilone, Giovannino Ciccone, Andrea Evangelista

المساهمون: Ricardi, U., Levis, M., Evangelista, A., Gioia, D. M., Sacchetti, G. M., Gotti, M., Re, A., Buglione, M., Pavone, V., Nardella, A., Nassi, L., Zanni, M., Franzone, P., Frezza, G. P., Pulsoni, A., Grapulin, L., Santoro, A., Rigacci, L., Simontacchi, G., Tani, M., Zaja, F., Abruzzese, E., Botto, B., Zilioli, V. R., Rota-Scalabrini, D., Freilone, R., Ciccone, G., Filippi, A. R., Zinzani, P. L., Ricardi U., Levis M., Evangelista A., Gioia D.M., Sacchetti G.M., Gotti M., Re A., Buglione M., Pavone V., Nardella A., Nassi L., Zanni M., Franzone P., Frezza G.P., Pulsoni A., Grapulin L., Santoro A., Rigacci L., Simontacchi G., Tani M., Zaja F., Abruzzese E., Botto B., Zilioli V.R., Rota-Scalabrini D., Freilone R., Ciccone G., Filippi A.R., Zinzani P.L.

المصدر: Blood Advances

مصطلحات موضوعية: Clinical Trials and Observations, Dacarbazine, Bleomycin, Vinblastine, law.invention, chemistry.chemical_compound, Randomized controlled trial, law, Antineoplastic Combined Chemotherapy Protocols, medicine, Clinical endpoint, Doxorubicin, Humans, Neoplasm Staging, Hodgkin Disease, Antineoplastic Combined Chemotherapy Protocol, business.industry, Hazard ratio, Hematology, Confidence interval, chemistry, ABVD, business, Nuclear medicine, medicine.drug, Human

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9b7535486b60d3f8dc20b8160c1abb9Test
https://hdl.handle.net/11368/3005933Test